Marcy K. Vallone
- Molecular Biology top 10%
- Hematology top 2%
- Oncology top 10%
- Genetics top 10%
- Pathology and Forensic Medicine
- Co-authors
- Christopher J. MolineauxLori KunkelOwen A. O’ConnorRobert Z. OrlowskiTina M. WooFrancesco ParlatiGuy J. LaidigSusan D. Demo
- Topics
- Ubiquitin and proteasome pathways (8 papers)Multiple Myeloma Research and Treatments (8 papers)Protein Degradation and Inhibitors (5 papers)
- Cited by
- HematologyOncologyMolecular Biology
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Marcy K. Vallone
13 papers receiving 863 citations
Hit Papers
Peers
Comparison fields: 5 of 55
- Molecular Biology 748
- Hematology 466
- Oncology 335
- Genetics 83
- Pathology and Forensic Medicine 77
Countries citing papers authored by Marcy K. Vallone
This map shows the geographic impact of Marcy K. Vallone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcy K. Vallone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcy K. Vallone more than expected).
Fields of papers citing papers by Marcy K. Vallone
This network shows the impact of papers produced by Marcy K. Vallone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcy K. Vallone. The network helps show where Marcy K. Vallone may publish in the future.
Co-authorship network of co-authors of Marcy K. Vallone
This figure shows the co-authorship network connecting the top 25 collaborators of Marcy K. Vallone. A scholar is included among the top collaborators of Marcy K. Vallone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcy K. Vallone. Marcy K. Vallone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 30 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 5 | |
| 6 | 3 | |
| 7 | 229 | |
| 8 | Antitumor Activity of PR-171, a Novel Irreversible Inhibitor of the Proteasomebreakdown → | 542 |
| 9 | 18 | |
| 10 | 43 | |
| 11 | 7 | |
| 12 | 9 | |
| 13 | 2 | |
| 14 | 13 |
About Marcy K. Vallone
Marcy K. Vallone is a scholar working on Hematology, Oncology and Hepatology, having authored 14 papers that have together received 904 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (8 papers), Multiple Myeloma Research and Treatments (8 papers) and Protein Degradation and Inhibitors (5 papers). The work is most often cited by research in Hematology (466 citations), Oncology (335 citations) and Molecular Biology (748 citations). Marcy K. Vallone has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Christopher J. Molineaux, Lori Kunkel, Owen A. O’Connor, Robert Z. Orlowski, Tina M. Woo, Francesco Parlati, Guy J. Laidig, Susan D. Demo, Mark K. Bennett and Mark S. Smyth. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.